Lion Raaz

Lion Raaz

Auto-generated profile, based on publicly available information

Lion Raaz

Max Planck Institute for Molecular Genetics

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 November 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
PMPaul-Lennard Mendez
Paul-Lennard Mendez
LRLion Va Raaz
Lion Va Raaz
JJJerome Jatzlau
Jerome Jatzlau
YXYunyun Xiao
Yunyun Xiao
PVPieter Vrancaert
Pieter Vrancaert
PKPetra Knaus
Petra Knaus
Background: Cardiovascular diseases are the leading cause of death worldwide with atherosclerosis as the main underlying pathology. A hallmark of atherosclerotic lesion formation is endothelial-to-mesenchymal transition (EndoMT) triggered by perturbed blood flow patterns at arterial bifurcations and curvatures. SMAD transcription factors (TFs), activated by bone morphogenetic protein (BMP) 9/10 or transforming growth factor beta (TGFβ) signaling, are indispensable for endothelial homeostasis. Yet, they also play a significant role in stimulating EndoMT. How different interacting co-factors mediate the shift towards a pathological SMAD response remains elusive. Methods: We generated endothelial cell (EC)-specific SMAD1/5 or SMAD2/3 knock-out mice and performed assay for transposase accessible chromatin sequencing (ATAC-Seq) of EC nuclei from regions of atheroprone (aortic arch) and atheroprotective (descending thoracic aorta) flow to identify transcriptional co-regulators of SMADs. We validated this using single-cell (sc)ATAC-Seq and immunofluorescence staining data from wild-type mice. To assess conservation of our findings for the human situation, we performed co-immunoprecipitation and proximity ligation assays in human aortic ECs (HAoECs). We exposed HAoECs to pathological or physiological ( i . e . oscillatory or pulsatile) flow and performed ATAC- and RNA-Seq. Next, transcriptomic and chromatin accessibility data were integrated and motif enrichment and TF footprinting analysis were performed. Finally, we used siRNA-mediated approaches, TF inhibition, and luciferase-based reporter gene assays to analyze the transcriptional response of target TFs and explored their presence in plaques of atheroprone low-density lipoprotein receptor-deficient mice. Results: We observed enrichment of FOXO TF family motifs in DNA loci with increased accessibility in response to atheroprone flow in vitro and in vivo . These motifs were associated with genes displaying enhanced mRNA expression. We observed that FOXO motifs are enriched in peaks lost upon EC-specific SMAD KO in mice. We identified SMADs and FOXO1 as interacting partners that form complexes upon atheroprone flow stimulation. Inhibitor experiments revealed that FOXO1 and SMADs mediate EndoMT upon atheroprone flow exposure by upregulating SNAI2 . Conclusion: We identified SMAD/FOXO1 complexes that mediate EndoMT in response to atheroprone flow. Targeting this interaction can potentially reduce atherosclerotic burden by interfering with pathological flow-induced EndoMT and thus disease progression.

15 September 2026 in Research Square
Verified
Preprint
Open access
PDF file
JAJurjan Aman
Jurjan Aman
BNBeau Neep
Beau Neep
LHLaura de Heus
Laura de Heus
LRLion Raaz
Lion Raaz
XSXiaoqing Sun
Xiaoqing Sun
HBHarm-Jan Bogaard
Harm-Jan Bogaard
SOX17 is an embryonic transcription factor implicated in arterial endothelial differentiation, but its function in the adult vasculature remains incompletely defined. Because genetic variation in SOX17 is associated with pulmonary arterial hypertension (PAH), a fatal disease marked by pulmonary vascular remodeling, we investigated whether SOX17 regulates endothelial mechanoadaptation. We show that SOX17 is enriched in pulmonary artery endothelial cells and is induced by laminar shear stress. Loss of SOX17 impaired shear-induced cell elongation, promoted intercellular gap formation, and compromised endothelial barrier function and regenerative capacity. SOX17 depletion reduced VE-cadherin and β-catenin abundance and disrupted adherens junction architecture in both two-dimensional and three-dimensional models. Transcriptomic profiling identified Semaphorin 3G (SEMA3G) as a downstream effector of SOX17, and CUT&RUN analysis revealed shear-dependent binding of SOX17 at regulatory regions of CDH5, ESAM and SEMA3G. Recombinant SEMA3G restored endothelial junction integrity following SOX17 depletion in vitro , and rescued vascular injury in endothelial-specific Sox17-knockout mice. Together, these findings identify SOX17 as a key regulator of endothelial barrier homeostasis under shear, and suggest that SOX17 deficiency sensitizes the arterial endothelium to injury.

14 January 2026 in Research Square
Verified
Preprint
Open access
PDF file
PKPetra Knaus
Petra Knaus
PMPaul Mendez
Paul Mendez
LRLion Raaz
Lion Raaz
YXYunyun Xiao
Yunyun Xiao
JJJerome Jatzlau
Jerome Jatzlau
ALAernout Luttun
Aernout Luttun
Endothelial-to-mesenchymal transition (EndMT) contributes to vascular remodeling and endothelial dysfunction in diseases such as atherosclerosis and pulmonary arterial hypertension. This process describes a gradual shift in which endothelial cells (ECs) lose expression of classical EC markers and acquire mesenchymal-like gene expression patterns and phenotypic traits. Although SMAD transcription factors are key regulators of EndMT, driven by mechanical cues from disturbed flow that activate BMP or TGFβ signaling, their weak DNA-binding affinity invoked the need for additional transcriptional co-factors to specify gene targets under pathophysiological flow conditions. Here, we identified FOXO1 as a transcriptional co-factor that cooperates with SMADs to regulate mesenchymal gene expression in ECs exposed to irregular flow. FOXO1 and SMADs co-occupy genomic loci and form transcriptional complexes. Although SMAD DNA binding is FOXO1-independent, FOXO1 activity is required for full induction of SMAD target genes. Notably, FOXO1 DNA-binding activity is essential for robust activation of EndMT-associated genes, as both pharmacological inhibition and siRNA-mediated depletion of FOXO1 attenuate SMAD target gene expression. Functionally, combined targeting of FOXO1 and SMAD signaling rescues EndMT-associated endothelial dysfunction in carotid arteries of mice. Our results describe FOXO1 as key integrator of SMAD-mediated EndMT signaling, linking it to pathogenic SMAD activation in disease contexts.